These are routine tax-covering sales tied to equity vesting, not discretionary portfolio moves. The amounts are immaterial relative to market cap. Monitor for any unexpected increase in insider selling volume or a Form 4 filing showing actual execution.
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+5- T+0 · Nov 3 $140.30entry
- T+1 · 13d ago +1.63%α −0.03% · $142.58
- T+5 · 7d ago −5.82%α −5.24% · $132.13
- T+9 · todayOpen
- T+20 · in 15d Pending
- T+60 · in 3mo Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Two Twist Bioscience officers filed Form 144 notices on November 3, 2026, signaling intent to sell shares. CFO Dennis Cho plans to sell 949 shares (~$128K) and Chief Commercial Officer Patrick Finn plans to sell 2,565 shares (~$347K), both to cover tax obligations from vested equity awards. The sales are small relative to the company's $11.5B market cap and follow a pattern of insider sales over the prior three months.
Key Facts
- CFO Dennis Cho filed Form 144 to sell 949 shares valued at ~$128,496
- CCO Patrick Finn filed Form 144 to sell 2,565 shares valued at ~$347,305
- Both sales are to cover tax obligations from restricted stock vesting on 11/02/2026
- Cho has sold shares on 7 prior occasions since August 2026 totaling ~$5.6M
- Finn has sold shares on 5 prior occasions since August 2026 totaling ~$15.2M
- The proposed sale date is 11/03/2026
- Combined proposed sale value is ~$475,801, or ~0.004% of market cap
Financial Impact
Combined ~$475,801 in proposed insider sales, representing ~0.004% of $11.5B market cap
Risk Factors
- Form 144 is an intent to sell; actual sales may not occur
- Both officers have a history of regular selling, reducing the signal value of this filing
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (TWST), Batch item 1 | 0001959173-26-007693 |
| Document: 0001959173-26-007693-index.html | 0001959173-26-007694 |
| Document: 0001959173-26-007693.txt | 0001959173-26-007693 |
| 144 Filing (TWST), Batch item 4 | 0001959173-26-007694 |
| Document: 0001959173-26-007694-index.html | 0001959173-26-007693 |
| Document: 0001959173-26-007694.txt | 0001959173-26-007693 |
Track record
47 reports on TWST
8 of 11 bullish or bearish reports moved the stock their way by T+20. Best: +55.24% at T+60 after the Aug 3, 2026 report. 10 of 12 went positive at some point.
Filters
- Nov 16, 2026today 144 Neutral 2/10 Entry $105.03 Now $111.60 +6.26% settles Dec 15
- Nov 16, 2026today 144 Neutral 2/10 Entry $105.16 Now $111.60 +6.12% settles Dec 15
- Nov 16, 2026today 144 Neutral 2/10 Entry $104.98 Now $111.60 +6.31% settles Dec 15
- Nov 16, 2026today 144 Neutral 2/10 Entry $105.61 Now $111.60 +5.67% settles Dec 15
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $104.03 Now $111.60 +7.28% settles Dec 15
- Nov 12, 20264d ago 8-K Bullish 6/10 Entry $114.22 Now $111.60 −2.29% settles Dec 11
- Nov 12, 20264d ago SC 13G/A Neutral 2/10 Entry $114.22 Now $111.60 −2.29% settles Dec 11
- Nov 10, 20266d ago SC 13G Neutral 3/10 Entry $132.13 Now $111.60 −15.54% settles Dec 9
- Nov 5, 202611d ago Insider Cluster Neutral 2/10 Entry $120.79 Now $111.60 −7.61% settles Dec 7
- Nov 5, 202611d ago SC 13G/A Neutral 2/10 Entry $120.61 Now $111.60 −7.47% settles Dec 4
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers